(redirected from Requip XL)
Also found in: Medical.


A dopamine agonist, C16H24N2O, used in its hydrochloride form to treat Parkinson's disease and restless legs syndrome.

[(p)rop(yl) + (am)in(o) + -ir- (probably alteration of (h)y(d)r(o)-) + (ind)ole.]


n ropinirol m
References in periodicals archive ?
Reddy's Laboratories has launched ropinirole hydrochloride XR (extended-release) tablets (2 mg, 4 mg, 6 mg, 8 mg and 12 mg), a bioequivalent generic version of Requip XL tablets in the United States.
In the regional portfolio, ahead of final year results due to be announced on Thursday, GlaxoSmithKline's drug Requip XL was again in the spotlight.
The agency set more conditions to be met before it can clear the longer-lasting formulation, Requip XL, to treat symptoms of the neurological disorder.
c) Mirapex ER and Pramipexole, Requip XL and Ropinirole
WASHINGTON -- The Actavis Group has received Food and Drug Administration approval of ropinirole extended-release tablets, 2 mg, 4 mg, 6 mg, 8 mg and 12 mg, a generic equivalent to GlaxoSmithKline PLC's Requip XL.
Azilect, along with levodopa and the dopamine agonists pramipexole (Boehringer Ingelheim's Mirapex ER, Mirapex, generics) and ropinirole (GlaxoSmithKline's Requip XL, Requip, generics) are mainstay treatments in the Parkinson's disease treatment algorithm, with the three-times-daily formulations of the dopamine agonists experiencing greater use among recently treated patients than their once-daily counterparts, according to claims data analysis.